Ribeiro Barbosa Jakeline, Sousa Bezerra Cristianne, Carvalho-Costa Filipe Anibal, Pimentel de Azevedo Carolina, Lopes Flores Geane, Baima Colares Jeová Keny, Malta Lima Danielle, Lampe Elisabeth, Melo Villar Lívia
Viral Hepatitis Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro 21040-900, Brazil.
Postgraduate Programme in Pathology, Federal University of Ceará State, Fortaleza CE 60430-160, Brazil.
Int J Environ Res Public Health. 2017 Jul 17;14(7):793. doi: 10.3390/ijerph14070793.
: HBV (Hepatitis B Virus) and HCV (Hepatitis C Virus) infections are more prevalent in vulnerable populations than the general population. The objective of this study was to investigate the prevalence of HBV and HCV infection in HIV-positive patients (GI), chronic renal failure (CRF) patients (GII) and coagulation disorder individuals (GIII). : A cross-sectional study was conducted from June 2014 to March 2015. Serum samples were tested for markers of hepatitis B and C by enzyme-linked immunosorbent assay (ELISA). Sociodemographic, epidemiological, clinical and laboratory data and accompanying statistical analyses were performed using Epi Info™ 7. : A total of 348 individuals were recruited, i.e., 154 HIV-positive, 143 CRF and 51 coagulopathy patients. Among them, more than 66% were men, and the predominant age group was 26-35 years in GI and 56-65 years in GIII. Most patients had more than 8 years of education (66.2% in GI, 60.6% in GIII and 46.1% in GII), with a family income between 100-400 dollars in more than 48% of patients. The prevalence of the HBsAg marker was 3.9%, 7% and 3.9%, total anti-HBc was 28.6%, 55.9% and 31.4%, and anti-HCV was 1.3%, 12.6% and 47% for GI, GII and GIII, respectively. However, the prevalence of anti-HBs was greater than 70% in all groups. : This study shows a high prevalence of HBV and HCV among specific groups compared to the general population. Factors such as age, income, number of sexual partners, sexually transmitted disease burden, blood transfusion history or blood products and blood transfusions before 1994 were associated with a higher prevalence for these infections.
乙肝病毒(HBV)和丙肝病毒(HCV)感染在弱势群体中比在普通人群中更为普遍。本研究的目的是调查HIV阳性患者(第一组)、慢性肾衰竭(CRF)患者(第二组)和凝血障碍患者(第三组)中HBV和HCV感染的患病率。
2014年6月至2015年3月进行了一项横断面研究。通过酶联免疫吸附测定(ELISA)检测血清样本中的乙肝和丙肝标志物。使用Epi Info™ 7进行社会人口统计学、流行病学、临床和实验室数据以及相关的统计分析。
共招募了348名个体,即154名HIV阳性患者、143名CRF患者和51名凝血障碍患者。其中,超过66%为男性,主要年龄组在第一组为26 - 35岁,在第三组为56 - 65岁。大多数患者接受过8年以上教育(第一组为66.2%,第三组为60.6%,第二组为46.1%),超过48%的患者家庭收入在100 - 400美元之间。第一组、第二组和第三组的乙肝表面抗原(HBsAg)标志物患病率分别为3.9%、7%和3.9%,乙肝核心抗体(total anti - HBc)分别为28.6%、55.9%和31.4%,丙肝抗体(anti - HCV)分别为1.3%、12.6%和47%。然而,所有组的乙肝表面抗体(anti - HBs)患病率均大于70%。
本研究表明,与普通人群相比,特定群体中HBV和HCV的患病率较高。年龄、收入、性伴侣数量、性传播疾病负担、输血史或1994年前的血液制品及输血等因素与这些感染的较高患病率相关。